Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 50268-720

4 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 50268-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 800mg (Label 5026872015 Sevelamer 2019 800mg)

Label 800mg (Label 5026872015 Sevelamer 2019 800mg)
Sevelamer Carbonate Tablets 800 mg film-coated oral tablets in a carton label. The label states Rx Only and contains 50 tablets (5 x 10) unit dose. It lists active ingredient sevelamer carbonate 800 mg, inactive ingredients, storage instructions, manufacturer AvPAK, and barcode. The label displays the NDC 50268-720-15 and AvPAK logo.*
FDA Label Image

Structure (Sevelamer Carbonate Tablets 1)

Structure (Sevelamer Carbonate Tablets 1)
Chemical structure diagram showing the molecular arrangement of Sevelamer Carbonate, including ammonium (NH3+), bicarbonate (HCO3-), and linked polymeric amine groups, as typically depicted in structural formula representations of this active ingredient.*
FDA Label Image

F-2 (Sevelamer Carbonate Tablets 2)

F-2 (Sevelamer Carbonate Tablets 2)
A line graph depicting the percentage of patients achieving a reduction of 2 mg/dL or more in serum phosphorus levels. The x-axis represents the reduction in serum phosphorus (mg/dL) ranging from -4 to 8, and the y-axis shows the percentage of patients from 0 to 100. Two lines are represented: one for Sevelamer Hydrochloride and another labeled Active Control, illustrating comparative efficacy in serum phosphorus reduction.*
FDA Label Image

F-3 (Sevelamer Carbonate Tablets 3)

F-3 (Sevelamer Carbonate Tablets 3)
A line graph showing phosphorus change from baseline over 52 study weeks. The x-axis represents study weeks, and the y-axis represents phosphorus change from baseline. Two data series are shown: Sevelamer Hydrochloride (black circles) and Active-Control (red squares), both demonstrating trends in phosphorus levels over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.